NEW YORK (Reuters Health) – When patients with advanced gastric cancer have not benefitted from one or two chemotherapy regimens for metastatic disease, salvage chemotherapy improves their overall…
NEW YORK (Reuters Health) – Results of a study conducted in Singapore indicate that vasopressin administered to patients in prolonged cardiac arrest does not improve survival to hospital…
NEW YORK (Reuters Health) – By accelerating recovery of gastrointestinal function, use of the opioid receptor antagonist alvimopan is associated with reduced mortality and morbidity following bowel resection,…
NEW YORK (Reuters Health) – In high-risk hypertensive patients with or without prior coronary artery disease, adding the angiotensin receptor II blocker valsartan to conventional non-ARB treatment reduces…
NEW YORK (Reuters Health) – Two independent studies have shown that reduced-activity variants of the cytochrome P450 2D6 (CYP2D6) enzyme are not associated with poorer disease control in…
NEW YORK (Reuters Health) – The success of radiofrequency ablation (RFA) for small renal tumors is strongly dependent on tumor size, according to a study in the April…
NEW YORK (Reuters Health) – In a randomized study, rates of bacteriuria were significantly higher in laboring women with epidurals who had intermittent bladder catheterization relative to those…
NEW YORK (Reuters Health) – The lipid-modifying effects of rosuvastatin (Crestor: AstraZeneca) are stronger than atorvastatin (Lipitor; Pfizer) in patients with an acute coronary syndrome (ACS), according to…
NEW YORK (Reuters Health) – Pregnancy rates are higher in patients of advanced reproductive age undergoing assisted reproduction when recombinant luteinizing hormone (LH) is added to controlled ovarian…
NEW YORK (Reuters Health) – A transdermal sumatriptan formulation, NP101, in development for acute treatment of migraine, remains effective during a year of successive uses, according to a…
NEW YORK (Reuters Health) – In real-world contemporary clinical practice, the use of the XIENCE V everolimus-eluting coronary stent is associated with lower mortality and reduced stent thrombosis…
NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study…
